(Alliance News) – The following stocks were the top gainers and losers on AIM this Thursday.
———-
AIM – WINNERS
———-
ImmuPharma PLC, up 90% to 2.28p, 12-month range 0.82p-3.00p. The drug discovery and development company hails “groundbreaking advances” in preclinical research in the field of autoimmune diseases. “We are delighted to share these significant results with ImmuPharma Biotech. This groundbreaking research confirms our confidence in P140 and its future therapeutic success and also creates potential new opportunities to strengthen our intellectual property portfolio, positioning us at the forefront of innovation in autoimmune disease therapies,” said Tim McCarthy, president and CEO of the company. The company is “not releasing detailed data in a timely manner” on the results because they are part of a continued expansion of its intellectual property portfolio. However, she said the findings pave the way for “earlier and more accurate diagnoses” and make it easier to identify patients who are most likely to respond to P140 treatment. The results also suggest an improvement in monitoring response to treatment.
———-
Cirata PLC, up 26% to 26.90 pence, 12-month range 19.05 pence-85.00 pence. The software solutions provider says it ended 2024 with the “strongest booking quarter” since the second quarter of 2022. Bookings for the final quarter of 2024 totaled $3.0 million, an improvement from 2.0 million. 7 million USD from the previous year and the 1.7 million USD from the third quarter. Annual bookings stand at USD 7.1 million for 2024, compared to USD 7.2 million for 2023.
———-
-AIM – LOSERS
———-
Impax Asset Management Group PLC, down 3.4% to 234.34 pence, 12-month range 220.50 pence-559.00 pence. The company says assets under management fell 8.3% quarter-on-quarter to £34.11 billion at the end of the first quarter to December 31. “This quarter we experienced relatively significant capital outflows, including the closing of our smallest mandate with St James’s Place and buybacks driven by industry consolidation in our institutional channel in the Asia Pacific region,” says the CEO Ian Simm. “More positively, we continued to see a slowdown in outflows from our main European distribution partner, BNP Paribas Asset Management, and our US mutual funds.” The company reports net outflows of £2.42 billion for the period, as well as a loss of £660 million due to performance, market movements and exchange rates.
———-
By Eric Cunha, Editor-in-Chief of Alliance News
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All rights reserved.
